The PE Ratio as of December 2025 (TTM) for North China Pharmaceutical Company Ltd. (600812.SS) is 51.36

According to North China Pharmaceutical Company Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 51.36. This represents a change of -16.82% compared to the average of 61.75 of the last 4 quarters.

North China Pharmaceutical Company Ltd. (600812.SS) Historical PE Ratio (quarterly & annually)

How has 600812.SS PE Ratio performed in the past?

The mean historical PE Ratio of North China Pharmaceutical Company Ltd. over the last ten years is 416.56. The current 51.36 PE Ratio has changed 1.13% with respect to the historical average. Over the past ten years (40 quarters), 600812.SS's PE Ratio was at its highest in in the December 2021 quarter at 6.16K. The PE Ratio was at its lowest in in the December 2017 quarter at -643.28.

North China Pharmaceutical Company Ltd. (600812.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of North China Pharmaceutical Company Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

North China Pharmaceutical Company Ltd. (600812.SS) Average PE Ratio

How has 600812.SS PE Ratio performed in the past?

The current PE Ratio of North China Pharmaceutical Company Ltd. (600812.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

North China Pharmaceutical Company Ltd. (600812.SS) PE Ratio vs. Peers

How is 600812.SS’s PE Ratio compared to its peers?

North China Pharmaceutical Company Ltd.’s PE Ratio is greater than KPC Pharmaceuticals, Inc. (17.79), less than Sichuan Huiyu Pharmaceutical Co., Ltd. (167.17), greater than Cisen Pharmaceutical Co., Ltd. (16.62), greater than Tianjin Ringpu Bio-Technology Co.,Ltd. (21.27), greater than Zhejiang Tianyu Pharmaceutical Co., Ltd. (43.23), greater than Shandong Lukang Pharmaceutical Co.,Ltd. (43.85), greater than Shandong Xinhua Pharmaceutical Company Limited (28.63), greater than Zhejiang Xianju Pharmaceutical Co.,Ltd. (33.22), greater than Heilongjiang ZBD Pharmaceutical Co., Ltd. (-27.99), greater than Changzhou Qianhong Biopharma CO.,LTD (22.98),

Build a custom stock screener for North China Pharmaceutical Company Ltd. (600812.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like North China Pharmaceutical Company Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

North China Pharmaceutical Company Ltd. (600812.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like North China Pharmaceutical Company Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.